Phreesia ROA 2019-2025 | PHR

Current and historical return on assets (ROA) values for Phreesia (PHR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Phreesia ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-04-30 $-0.04B $0.40B -11.01%
2025-01-31 $-0.06B $0.39B -15.49%
2024-10-31 $-0.08B $0.38B -22.43%
2024-07-31 $-0.10B $0.36B -27.32%
2024-04-30 $-0.12B $0.37B -32.94%
2024-01-31 $-0.14B $0.37B -38.36%
2023-10-31 $-0.15B $0.38B -40.31%
2023-07-31 $-0.15B $0.34B -41.89%
2023-04-30 $-0.16B $0.35B -42.15%
2023-01-31 $-0.18B $0.37B -42.62%
2022-10-31 $-0.18B $0.40B -41.44%
2022-07-31 $-0.18B $0.43B -37.74%
2022-04-30 $-0.16B $0.46B -30.89%
2022-01-31 $-0.12B $0.49B -21.92%
2021-10-31 $-0.08B $0.53B -16.06%
2021-07-31 $-0.05B $0.55B -11.25%
2021-04-30 $-0.03B $0.56B -9.24%
2021-01-31 $-0.03B $0.33B -10.95%
2020-10-31 $-0.02B $0.34B -11.25%
2020-07-31 $-0.02B $0.16B -11.32%
2020-04-30 $-0.08B $0.16B -51.96%
2020-01-31 $-0.09B $0.16B -76.99%
2019-07-31 $-0.10B $0.16B -242.94%
2019-04-30 $-0.04B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.677B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.946B 59.99
Hims & Hers Health (HIMS) United States $12.884B 133.86
Tempus AI (TEM) United States $12.253B 0.00
IRhythm Technologies (IRTC) United States $4.705B 0.00
Inspire Medical Systems (INSP) United States $3.914B 61.16
Privia Health (PRVA) United States $2.805B 191.75
Hinge Health (HNGE) United States $2.743B 0.00
Schrodinger (SDGR) United States $1.958B 0.00
Enovis (ENOV) United States $1.904B 10.62
Clover Health Investments (CLOV) United States $1.511B 0.00
Omnicell (OMCL) United States $1.424B 25.12
Azenta (AZTA) United States $1.410B 65.55
10x Genomics (TXG) United States $1.327B 0.00
Fulgent Genetics (FLGT) United States $0.661B 0.00
Claritev (CTEV) United States $0.646B 0.00
Butterfly Network (BFLY) United States $0.623B 0.00
Talkspace (TALK) United States $0.518B 154.75
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.372B 824.67
Outset Medical (OM) United States $0.362B 0.00
Health Catalyst (HCAT) United States $0.276B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
American Well (AMWL) United States $0.112B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.095B 3.61
111 (YI) China $0.064B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.027B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00